Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Prospective food consumption is a subjective measure of appetite used extensively in clinical research to evaluate hunger and satiety levels. It is typically assessed using a Visual Analogue Scale (VAS) where participants respond to the question, 'How much food do you think you could eat right now?' (Flint et al., 2000). While it is a reliable indicator of an individual's motivation to eat, it is a behavioral and psychological endpoint rather than a biological molecule or receptor. In pharmacological studies, prospective food consumption serves as a key pharmacodynamic marker to assess the efficacy of anti-obesity medications, such as GLP-1 receptor agonists, which reduce this measure by acting on the central nervous system to enhance satiety (Blundell et al., 2010). Because it represents a subjective state, it is often used in conjunction with other measures like 'fullness' and 'desire to eat' to provide a comprehensive profile of a drug's effect on appetite regulation.
Not applicable as this is a psychological and behavioral measurement endpoint rather than a molecular target.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Prospective food consumption (PFC).